Cargando…
P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621548/ http://dx.doi.org/10.1097/01.HS9.0000890788.87924.9c |
| _version_ | 1784821582738227200 |
|---|---|
| author | Buhtoiarov, Ilia Hill, Brian Kirsch, Ilan Richter, Nancy Hanna, Rabi |
| author_facet | Buhtoiarov, Ilia Hill, Brian Kirsch, Ilan Richter, Nancy Hanna, Rabi |
| author_sort | Buhtoiarov, Ilia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621548 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215482022-11-01 P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma Buhtoiarov, Ilia Hill, Brian Kirsch, Ilan Richter, Nancy Hanna, Rabi Hemasphere Genomics, Biology & Microenvironment Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621548/ http://dx.doi.org/10.1097/01.HS9.0000890788.87924.9c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Genomics, Biology & Microenvironment Buhtoiarov, Ilia Hill, Brian Kirsch, Ilan Richter, Nancy Hanna, Rabi P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma |
| title | P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma |
| title_full | P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma |
| title_fullStr | P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma |
| title_full_unstemmed | P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma |
| title_short | P055: Validation of the tumor cell-specific rearranged IgG-encoding circulating cell-free DNA for the treatment response monitoring in patients with classic Hodgkin lymphoma |
| title_sort | p055: validation of the tumor cell-specific rearranged igg-encoding circulating cell-free dna for the treatment response monitoring in patients with classic hodgkin lymphoma |
| topic | Genomics, Biology & Microenvironment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621548/ http://dx.doi.org/10.1097/01.HS9.0000890788.87924.9c |
| work_keys_str_mv | AT buhtoiarovilia p055validationofthetumorcellspecificrearrangediggencodingcirculatingcellfreednaforthetreatmentresponsemonitoringinpatientswithclassichodgkinlymphoma AT hillbrian p055validationofthetumorcellspecificrearrangediggencodingcirculatingcellfreednaforthetreatmentresponsemonitoringinpatientswithclassichodgkinlymphoma AT kirschilan p055validationofthetumorcellspecificrearrangediggencodingcirculatingcellfreednaforthetreatmentresponsemonitoringinpatientswithclassichodgkinlymphoma AT richternancy p055validationofthetumorcellspecificrearrangediggencodingcirculatingcellfreednaforthetreatmentresponsemonitoringinpatientswithclassichodgkinlymphoma AT hannarabi p055validationofthetumorcellspecificrearrangediggencodingcirculatingcellfreednaforthetreatmentresponsemonitoringinpatientswithclassichodgkinlymphoma |